scholarly journals Bone Mineral Density in Young Women on Methadone Substitution

2011 ◽  
Vol 89 (3) ◽  
pp. 228-233 ◽  
Author(s):  
Gabriella Milos ◽  
Luigi M. Gallo ◽  
Branca Sosic ◽  
Daniel Uebelhart ◽  
Gerhard Goerres ◽  
...  
2012 ◽  
Vol 25 (3) ◽  
pp. 331-340 ◽  
Author(s):  
Susan Ziglar ◽  
Tracy S. Hunter

Maximizing bone mass in youth is touted as the best strategy to offset the natural losses of aging and the menopausal transition. Not achieving maximum peak bone mineral density (BMD) is an independent risk factor for osteoporosis and thus a public health concern. Adolescence is a critical time of bone mineralization mediated by endogenous estradiol. Research has shown that the highest velocity of bone mass accrual occurs 1 year before menarche and after the first 3 years. Low-peak attainment of BMD in young women is associated with contributing factors such as diets low in calcium, eating disorders, lack of exercise, smoking, and low estrogen states. Oral contraceptives (OCs) suppress endogenous estradiol production by suppressing the hypothalamic–pituitary–ovarian axis. Thus, OCs, by replacing endogenous estradiol with ethinyl estradiol (EE), establish and maintain new hormone levels. The early initiation and the use of very low dose of EE raises the possibility that bone mass accrual at a critical time of bone mineralization in young women or adolescents may be jeopardized. This review examines the studies of BMD in adolescents and young women that use combination hormonal contraception. Some studies had inherent limitations, such as small trial, poor control of confounders, failure to exclude women with prior use of hormonal contraceptives, or prior pregnancy from control groups. The vast majority of reviewed studies showed OCs containing 20 to 30 µg of EE interfere with acquisition of peak BMD. Limited numbers of studies examine the effects of OCs containing 35 µg on adolescents and young adults. Additionally, studies are needed evaluating the progestin component of OCs as their differing androgenic properties may affect bone mineralization as well.


1998 ◽  
Vol 68 (3) ◽  
pp. 749-754 ◽  
Author(s):  
D Teegarden ◽  
R M Lyle ◽  
G P McCabe ◽  
L D McCabe ◽  
W R Proulx ◽  
...  

2010 ◽  
Vol 24 (S1) ◽  
Author(s):  
Jeannette Michele Beasley ◽  
Laura E Ichikawa ◽  
Brett A. Ange ◽  
Leslie Spangler ◽  
Andrea Z LaCroix ◽  
...  

2003 ◽  
Vol 35 (Supplement 1) ◽  
pp. S77
Author(s):  
L E. Miller ◽  
S M. Nickols-Richardson ◽  
D F. Wootten ◽  
L M. Pierson ◽  
W K. Ramp ◽  
...  

JAMA ◽  
1993 ◽  
Vol 270 (24) ◽  
pp. 2926-2927 ◽  
Author(s):  
R. R. Recker

Nutrients ◽  
2019 ◽  
Vol 12 (1) ◽  
pp. 21
Author(s):  
Katie Schraders ◽  
Giancarla Zatta ◽  
Marlena Kruger ◽  
Jane Coad ◽  
Janet Weber ◽  
...  

We would like to thank Moran and Sanchez Fernandez [...]


Author(s):  
Emma T Callegari ◽  
Suzanne M Garland ◽  
Alexandra Gorelik ◽  
Cherie Y Chiang ◽  
John D Wark

Background Bone turnover markers (BTMs) may provide insight into bone health in young women, but have been little studied in this demographic. We aimed to explore the association between body composition, hormonal contraception, bone mineral density and biochemical parameters and BTMs in young women. Methods Participants were community-dwelling females aged 16–25 years, living in Victoria, Australia. Carboxy-terminal cross-linking telopeptide of type 1 collagen (CTX) and total procollagen type 1 N-propeptide (P1NP) were analysed on the Roche Elecsys automated analyzer. A total of 305 were evaluated, after excluding participants with medical conditions or medications (except hormonal contraceptives), which may affect bone metabolism. Results Median (Q1, Q3) BTM values were 540 (410, 690) ng/L for CTX and 61.7 (46.2, 83.7) µg/L for P1NP. Serum CTX and P1NP were inversely associated with chronological age ( P < 0.001), transferrin ( P < 0.020) and serum dehydroepiandrosterone sulphate concentration ( P < 0.001). BTM values were up to 22% lower in combined oral contraceptive (COC) pill users ( P < 0.001). Serum CTX was inversely associated with per cent body fat ( P = 0.009) and tibial cortical volumetric bone mineral density (vBMD; P = 0.003). Serum P1NP concentrations were 23  µg/L higher in participants who reported using an osteopath in the previous year ( P = 0.007). Conclusions These data suggest that BTMs are influenced by age, COC use, body composition, iron status and hormonal profiles. Higher CTX values were associated with lower tibial cortical vBMD. Examining BTMs in relation to interventions aimed at improving bone health in young women is warranted.


Sign in / Sign up

Export Citation Format

Share Document